These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
115 related items for PubMed ID: 8627866
1. Renal cell carcinoma in children: the Detroit experience. Freedman AL, Vates TS, Stewart T, Padiyar N, Perlmutter AD, Smith CA. J Urol; 1996 May; 155(5):1708-10. PubMed ID: 8627866 [Abstract] [Full Text] [Related]
2. Renal cell carcinoma in children: experience at a single institution in Japan. Asanuma H, Nakai H, Takeda M, Shishido S, Tajima E, Kawamura T, Hara H, Morikawa Y, Kawamura T. J Urol; 1999 Oct; 162(4):1402-5. PubMed ID: 10492224 [Abstract] [Full Text] [Related]
3. Renal cell carcinoma with renal vein and inferior vena caval involvement: clinicopathological features, surgical techniques and outcomes. Parekh DJ, Cookson MS, Chapman W, Harrell F, Wells N, Chang SS, Smith JA. J Urol; 2005 Jun; 173(6):1897-902. PubMed ID: 15879771 [Abstract] [Full Text] [Related]
4. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate. Permpongkosol S, Bagga HS, Romero FR, Sroka M, Jarrett TW, Kavoussi LR. J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227 [Abstract] [Full Text] [Related]
6. Pediatric renal cell carcinoma: single institution 25-year case series and initial experience with partial nephrectomy. Cook A, Lorenzo AJ, Salle JL, Bakhshi M, Cartwright LM, Bagi D, Farhat W, Khoury A. J Urol; 2006 Apr; 175(4):1456-60; discussion 1460. PubMed ID: 16516019 [Abstract] [Full Text] [Related]
7. Impact of clinicopathological parameters in patients treated for renal cell carcinoma. Dall'Oglio MF, Arap MA, Antunes AA, Cury J, Leite KR, Srougi M. J Urol; 2007 May; 177(5):1687-91. PubMed ID: 17437783 [Abstract] [Full Text] [Related]
8. Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection. Pantuck AJ, Zisman A, Dorey F, Chao DH, Han KR, Said J, Gitlitz BJ, Figlin RA, Belldegrun AS. J Urol; 2003 Jun; 169(6):2076-83. PubMed ID: 12771723 [Abstract] [Full Text] [Related]
10. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma. Ward JF, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H. J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492 [Abstract] [Full Text] [Related]
11. Renal cell carcinoma in children. Prognostic factors. Al-Shabanah MO, Jenkin DR, Khafaga YO, Al-Zahrani AM, Danjoux C, Greenberg M. Saudi Med J; 2004 Nov; 25(11):1583-6. PubMed ID: 15573183 [Abstract] [Full Text] [Related]
12. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. Van Poppel H, Vandendriessche H, Boel K, Mertens V, Goethuys H, Haustermans K, Van Damme B, Baert L. J Urol; 1997 Jul; 158(1):45-9. PubMed ID: 9186320 [Abstract] [Full Text] [Related]
13. Characteristics and clinical outcomes of renal cell carcinoma in children: a single center experience. Baek M, Jung JY, Kim JJ, Park KH, Ryu DS. Int J Urol; 2010 Aug; 17(8):737-40. PubMed ID: 20586819 [Abstract] [Full Text] [Related]
14. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma. Dall'Oglio MF, Ribeiro-Filho LA, Antunes AA, Crippa A, Nesrallah L, Gonçalves PD, Leite KR, Srougi M. J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167 [Abstract] [Full Text] [Related]
15. Prognostic significance of the 1997 TNM classification of renal cell carcinoma. Javidan J, Stricker HJ, Tamboli P, Amin MB, Peabody JO, Deshpande A, Menon M, Amin MB. J Urol; 1999 Oct; 162(4):1277-81. PubMed ID: 10492179 [Abstract] [Full Text] [Related]
17. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma. Vasselli JR, Yang JC, Linehan WM, White DE, Rosenberg SA, Walther MM. J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825 [Abstract] [Full Text] [Related]
18. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience. Kassouf W, Sanchez-Ortiz R, Tamboli P, Jonasch E, Merchant MM, Spiess PE, Wood CG. Urology; 2007 May; 69(5):835-8. PubMed ID: 17482917 [Abstract] [Full Text] [Related]
19. [Transabdominal radical nephrectomy for renal cell carcinoma: an experience on 155 patients]. Chen XF, Zhou FJ, Han H, Qin ZK, Liu ZW, Yu SL, Li YH, Wang H, Hou GL. Ai Zheng; 2007 May; 26(5):528-32. PubMed ID: 17672946 [Abstract] [Full Text] [Related]
20. Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology. Kassouf W, Sanchez-Ortiz R, Tamboli P, Tannir N, Jonasch E, Merchant MM, Matin S, Swanson DA, Wood CG. J Urol; 2007 Nov; 178(5):1896-900. PubMed ID: 17868729 [Abstract] [Full Text] [Related] Page: [Next] [New Search]